The company reported revenues of $1.8 million for the quarter ended Dec. 31, representing a 5.8 percent increase from the same time period of 2018. DarioHealth also saw a 277 percent year-over-year increase in gross profits during the fourth quarter of 2019 — from $223,000 to $840,000 — due primarily to increases in revenues from its membership plans.
During that time period, DarioHealth made memberships to its digital diabetes management platform, previously only available for purchase online, available in brick-and-mortar Best Buy stores, with plans to expand to other physical retail locations. Shortly after, DarioHealth began offering its digital tool through the Walmart website.
More recently, the MyDario system — comprising a handheld blood glucose measurement device and an FDA-cleared tracking app — went live on supermarket chain Albertsons’ online marketplace in late February.
More articles on consumerism:
Google coronavirus website quickly overwhelmed, reaches capacity following launch
Verily launches online coronavirus triage tool in California
Lyft extends partnership with patient transportation platform
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
